日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

L-RNA aptamer-based CXCL12 inhibition combined with radiotherapy and bevacizumab in newly-diagnosed glioblastoma: expansion of the phase I/II GLORIA trial.

L-RNA 适配体 CXCL12 抑制剂联合放射疗法和贝伐单抗治疗新诊断的胶质母细胞瘤:I/II 期 GLORIA 试验的扩展。

Giordano Frank A, Layer Julian P, Turiello Roberta, Friker Lea L, Mirallas Oriol, Pregler Barbara E F, Potthoff Anna-Laura, Zeyen Thomas, Weller Johannes, Sperk Elena, Sahm Katharina, Oster Christoph, Kebir Sied, Hambsch Peter, Schäfer Niklas, Kadzik Sebastian, Renovanz Mirjam, Pietsch Torsten, Bisdas Sotirios, Sepúlveda-Sánchez Juan Manuel, Gómez-Puerto Diego, Vieito Maria, Platten Michael, Gkika Eleni, Grauer Oliver M, Tabatabai Ghazaleh, Schneider Matthias, Glas Martin, Seidel Clemens, Herrlinger Ulrich, Hölzel Michael

IL-17A-producing NKp44(-) group 3 innate lymphoid cells accumulate in Familial Adenomatous Polyposis duodenal tissue.

IL-17A 产生 NKp44(-) 组 3 先天性淋巴细胞在家族性腺瘤性息肉病十二指肠组织中积聚

Kaiser Kim M, Raabe Jan, ToVinh Michael, Hack Gudrun, Ahmad Sarah, Müller Niko, Cassella Julia, Walravens Sofia I, Alfaro Paula, Arias Garcia Lauren, Kaczmarek Dominik J, Marwitz Tim, Goeser Felix, Nischalke Hans Dieter, Lutz Philipp, Sommer Nils, Vilz Tim, Toma Marieta, Steiner Susanne, Hommerding Oliver, Oldenburg Johannes, Hölzel Michael, Kadzik Sebastian, Maas Alexander, Eckrich Jonas, Zumfelde Philipp, Shakeri Farhad, Nesic Svetozar, Buness Andreas, De Caro Emilia, Becker Matthias, Beyer Marc D, Ulas Thomas, Aschenbrenner Anna C, Steinheuer Lisa M, Thurley Kevin, Kroh Sandy, Uecker Ralf, Hauser Anja E, Gohr Florian N, Schmidt Florian I, Wang Danni, Held Kathrin, Baranov Olga, Geldmacher Christof, Strassburg Christian P, Hüneburg Robert, Krämer Benjamin, Nattermann Jacob